Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 53.27 +0.39 (+0.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 ... 20 21 22 23 24 25 26 27 28 ... 31 32 Next > Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran April 25, 2022 Terran Biosciences is slowly but surely finding its place in the psychedelics industry. Via Benzinga Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ April 22, 2022 Via Benzinga 4 Undervalued Biotech Stocks to Add to Your Buy List April 20, 2022 These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns. Via InvestorPlace Why Did Truist Lower IGM Biosciences' Price Target? March 30, 2022 Via Benzinga Why Is IGM Biosciences (IGMS) Stock Up Today? March 29, 2022 Here are the various catalysts investors in IGM Biosciences and IGMS stock are watching today as shares more than double. Via InvestorPlace How To Attend Sanofi Q1 2022 Earnings Conference Call April 19, 2022 Sanofi (NASDAQ:SNY) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results. Via Benzinga As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ April 18, 2022 In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a... Via Benzinga Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine April 14, 2022 Via Benzinga Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027 April 13, 2022 Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent... Via FinancialNewsMedia Exposures COVID-19 BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines April 11, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Friday Stocks Update April 08, 2022 Royal Dutch Shell rose again on its earnings but is still at a p/e ratio of under 11x earnings. Via Talk Markets What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates? April 07, 2022 Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier. Via Benzinga The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More April 07, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Stocks That Hit 52-Week Highs On Thursday April 07, 2022 On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... Via Benzinga Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation April 07, 2022 The Via Benzinga Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ April 05, 2022 Via Benzinga Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May April 01, 2022 Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business. Via Benzinga House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month April 01, 2022 The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare. Via Benzinga EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine March 30, 2022 Via Benzinga The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict March 30, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide March 29, 2022 U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday. Via Benzinga Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness March 29, 2022 President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country Via Benzinga 53 Biggest Movers From Yesterday March 30, 2022 Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... Via Benzinga Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump March 29, 2022 U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday. Via Benzinga 36 Stocks Moving In Tuesday's Mid-Day Session March 29, 2022 Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (... Via Benzinga Mid-Morning Market Update: Markets Open Higher; McCormick Profit Beats Estimates March 29, 2022 U.S. stocks opened on a strong note on Tuesday, with the Dow jumping around 350 points this morning. Via Benzinga IGM Biosciences Shares Surge After Oncology/Immunology Pact With Sanofi March 29, 2022 Sanofi SA (NASDAQ: SNY) and IGM Biosciences Inc (NASDAQ: IGMS) have signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against Via Benzinga The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia March 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 20 Stocks Moving in Tuesday's Pre-Market Session March 29, 2022 Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) rose 40.1% to $21.00 in pre-market trading following announcement of collaboration with Sanofi (NASDAQ: SNY). Guardforce AI Co.,... Via Benzinga < Previous 1 2 ... 20 21 22 23 24 25 26 27 28 ... 31 32 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
